ZA936137B - Method of treatment of reversible obstructive airways diseases - Google Patents
Method of treatment of reversible obstructive airways diseasesInfo
- Publication number
- ZA936137B ZA936137B ZA936137A ZA936137A ZA936137B ZA 936137 B ZA936137 B ZA 936137B ZA 936137 A ZA936137 A ZA 936137A ZA 936137 A ZA936137 A ZA 936137A ZA 936137 B ZA936137 B ZA 936137B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- obstructive airways
- airways diseases
- reversible obstructive
- reversible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929218027A GB9218027D0 (en) | 1992-08-25 | 1992-08-25 | Novel method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA936137B true ZA936137B (en) | 1994-02-21 |
Family
ID=10720906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA936137A ZA936137B (en) | 1992-08-25 | 1993-08-20 | Method of treatment of reversible obstructive airways diseases |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU4967193A (en) |
GB (1) | GB9218027D0 (en) |
IL (1) | IL106751A0 (en) |
MX (1) | MX9305152A (en) |
WO (1) | WO1994004148A1 (en) |
ZA (1) | ZA936137B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP223198A0 (en) * | 1998-03-06 | 1998-04-02 | Fujisawa Pharmaceutical Co., Ltd. | New use |
GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
PT1666028E (en) | 1999-10-29 | 2010-06-15 | Novartis Ag | Dry powder compositions having improved dispersivity |
US6878751B1 (en) * | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
AR035411A1 (en) * | 2000-12-29 | 2004-05-26 | Fujisawa Pharmaceutical Co | USE OF A TACROLIMUS DERIVATIVE TO MANUFACTURE A NEUROTROPHIC AGENT, COMPOSITIONS AND MANUFACTURING ITEMS OR KITS THAT UNDERSTAND IT, METHOD FOR MANUFACTURING AN AGENT THAT UNDERSTANDS AND FABRICS AND GRAINTS WITH A NERVOUS CELL TREATED WITH THIS COMPOSITE |
JP2007518692A (en) * | 2004-01-20 | 2007-07-12 | アステラス製薬株式会社 | How to treat erectile dysfunction |
MX2019005504A (en) | 2016-11-10 | 2019-08-12 | Novartis Ag | Bmp potentiators. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU630866B2 (en) * | 1987-12-09 | 1992-11-12 | Fisons Plc | Macrocyclic compounds |
IE64214B1 (en) * | 1989-06-06 | 1995-07-26 | Fujisawa Pharmaceutical Co | Macrolides for the treatment of reversible obstructive airways diseases |
GR1001225B (en) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Novel macrocyclic compositions and new application method thereof |
CA2054983A1 (en) * | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Suspendible composition and process for preparing the same |
-
1992
- 1992-08-25 GB GB929218027A patent/GB9218027D0/en active Pending
-
1993
- 1993-08-20 AU AU49671/93A patent/AU4967193A/en not_active Abandoned
- 1993-08-20 WO PCT/GB1993/001769 patent/WO1994004148A1/en active Application Filing
- 1993-08-20 ZA ZA936137A patent/ZA936137B/en unknown
- 1993-08-20 IL IL106751A patent/IL106751A0/en unknown
- 1993-08-25 MX MX9305152A patent/MX9305152A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994004148A1 (en) | 1994-03-03 |
GB9218027D0 (en) | 1992-10-14 |
AU4967193A (en) | 1994-03-15 |
MX9305152A (en) | 1994-05-31 |
IL106751A0 (en) | 1993-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3067995A (en) | Method for treatment of sleep apnea | |
HU9302875D0 (en) | Method for producing carboxyc acid derivatives and medical preparatives containing them | |
EP0421946A3 (en) | 3-indolepyruvic acid derivatives their method of production and therapeutic use | |
AU7682991A (en) | Heat controller and method for heat treatment of metal | |
AU8910891A (en) | Treatment of lung diseases | |
IL115015A0 (en) | Methods of inhibiting demyelinating and desmyelinating diseases | |
AU5960394A (en) | Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases | |
PL309600A1 (en) | Pharmaceutical compositions for preventing and treating neoplastic diseases and method of obtaining them | |
HU9402709D0 (en) | Pentofixillin for producing pharmaceutical compositions for treating lung diseases of granuloma and fibrozis | |
ZA936137B (en) | Method of treatment of reversible obstructive airways diseases | |
EP0460480A3 (en) | Bacterin for the treatment of necrophorum diseases and a method for the production thereof | |
ZA932303B (en) | Medicament for the treatment of airways inflammation and airways hyperresponsiveness | |
GB9202196D0 (en) | Method of treatment | |
AU2992295A (en) | Therapeutic method and compounds of use therein | |
AU6097394A (en) | Method for the treatment of respiratory disease | |
GB2266241B (en) | Treatment of pastures | |
GB9201391D0 (en) | Method of treatment | |
HU9203841D0 (en) | Method for producing preparative applicable for prevention and treatment of hoof diseases | |
GB9319897D0 (en) | Method for the treatment and shaping of hair | |
GB9207595D0 (en) | Treatment of pastures | |
ZA936136B (en) | Treatment of skin diseases | |
HU9301856D0 (en) | Application of glutarimide derivatives for treating depressive and maniacal diseases | |
AU3286893A (en) | Therapeutic device and method of treatment | |
IL103663A0 (en) | A device and method for the treatment of rheumatic diseases | |
BG95955A (en) | Method for the preparation of therapeutical means of arthrosis treatment |